Interclean Shanghai

Lynch Syndrome- AI Enhances Colorectal Cancer Detection

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

EU Begins Revision of Medical Device...

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical...

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI...

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

In the presence of Lynch syndrome, researchers at the National Center for Hereditary Tumor Diseases (NZET) at Bonn University Hospital have demonstrated that artificial intelligence (AI) can augment the efficacy of colonoscopy. The study results have been posted online in the United European Gastroenterology Journal.

Lynch syndrome (LS), also known as hereditary non-polyposis colorectal cancer (HNPCC), is the most prevalent hereditary colorectal cancer syndrome. According to estimates, it is thought to impact about 300,000 people in Germany alone. Two to three percent of all colon cancers are caused by LS. Defects in the genes that are in charge of mending the DNA that makes up human genetic material cause it. Children of affected individuals have a 50% chance of inheriting the pathologically altered genetic disposition (mutation), which increases their risk of developing colon cancer at an early age. Colonoscopy surveillance is therefore advised here on a yearly to two-year basis.

However, despite such consistent endoscopic monitoring, the head of the hepatogastroenterology section at UKB’s Medical Clinic I, Prof. Jacob Nattermann, notes that the risk of colorectal cancer in those affected remains elevated. The reason for this, according to the researchers, is that adenomas, which are possible origins of colorectal cancer, are still largely missed by colonoscopy. Even seasoned gastroenterologists run the danger of missing small and flat adenomas, according to Prof. Nattermann.

According to recent statistics, computer-aided detection (CADe), also known as artificial intelligence (AI)-assisted colonoscopy, may aid in boosting the population’s adenoma detection rates (ADR). So, explains Robert Hüneburg, senior physician at UKB’s Medical Clinic I, the purpose of their study was to assess the diagnostic performance of AI-assisted colonoscopy in patients with Lynch syndrome.

Thus, between December 2021 and December 2022, 46 LS patients were researched using traditional endoscopy and 50 LS patients using AI-assisted colonoscopy in close partnership with the Institute of Medical Informatics, Statistics, and Epidemiology, University of Leipzig. Here, adenomas were found by substantially more of the AI-assisted examinations (36%) than the conventional examinations (26.1%). According to Hüneburg, this was primarily because of much enhanced flat adenomas identification. In conclusion, this study was the first in the world to gather data indicating that AI-assisted real-time colonoscopy is a viable strategy to increase flat adenomas’ detection during endoscopic surveillance of LS patients. According to these findings, bigger multicentre research is now being planned by the department because of the small sample size, according to Prof. Nattermann.

Latest stories

Related stories

EU Begins Revision of Medical Device Regulatory Framework

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical Devices Regulation

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI Rollout in the NHS

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »